(HELE) Helen of Troy - Ratings and Ratios
Kitchenware, Hydration, Backpacks, Hair Care, Wellness Devices
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 52.1% |
| Value at Risk 5%th | 74.2% |
| Relative Tail Risk | -13.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.45 |
| Alpha | -92.23 |
| CAGR/Max DD | -0.51 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.546 |
| Beta | 1.302 |
| Beta Downside | 1.558 |
| Drawdowns 3y | |
|---|---|
| Max DD | 87.89% |
| Mean DD | 45.67% |
| Median DD | 48.99% |
Description: HELE Helen of Troy December 26, 2025
Helen of Troy Ltd. (NASDAQ: HELE) designs, manufactures, and markets a diversified portfolio of consumer products across two segments – Home & Outdoor and Beauty & Wellness – serving North America, Europe, the Middle East, Africa, APAC and Latin America.
The Home & Outdoor segment includes food-storage and kitchen tools, insulated beverageware, and a range of travel-and-sports packs (e.g., OXO, Hydro Flask, Osprey). The Beauty & Wellness segment covers hair-care appliances and grooming tools (Hot Tools, Curlsmith) as well as health-monitoring devices and water-air filtration systems (PUR).
In FY 2023 the company generated $2.0 billion of revenue, up 5 % year-over-year, with an adjusted EBITDA margin of ~13 % and a diluted EPS of $2.10 – both modestly above the household-appliance sub-industry averages, reflecting strong brand pricing power and efficient supply-chain management.
Key drivers for HELE include continued consumer spending on premium home-goods as remote-work persists, and the secular shift toward health-focused indoor air-quality products, which have grown at ~8 % CAGR globally. However, exposure to raw-material cost volatility (e.g., plastics, aluminum) and a modest slowdown in discretionary retail traffic remain material risks.
For a deeper, data-driven valuation, see the HELE profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-792.5m TTM) > 0 and > 6% of Revenue (6% = 108.1m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -0.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 24.97% (prev 25.04%; Δ -0.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 94.8m > Net Income -792.5m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.0m) change vs 12m ago 0.67% (target <= -2.0% for YES) |
| Gross Margin 46.72% (prev 48.04%; Δ -1.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 67.83% (prev 64.27%; Δ 3.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.30 (EBITDA TTM -198.9m / Interest Expense TTM 58.8m) >= 6 (WARN >= 3) |
Altman Z'' 1.61
| (A) 0.19 = (Total Current Assets 1.00b - Total Current Liabilities 554.1m) / Total Assets 2.34b |
| (B) 0.20 = Retained Earnings (Balance) 468.4m / Total Assets 2.34b |
| (C) -0.10 = EBIT TTM -252.8m / Avg Total Assets 2.66b |
| (D) 0.32 = Book Value of Equity 469.3m / Total Liabilities 1.49b |
| Total Rating: 1.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.04
| 1. Piotroski 3.50pt |
| 2. FCF Yield 5.99% |
| 3. FCF Margin 4.48% |
| 4. Debt/Equity 1.11 |
| 5. Debt/Ebitda -4.63 |
| 6. ROIC - WACC (= -13.92)% |
| 7. RoE -67.60% |
| 8. Rev. Trend -55.03% |
| 9. EPS Trend -57.23% |
What is the price of HELE shares?
Over the past week, the price has changed by -1.83%, over one month by -6.44%, over three months by -4.18% and over the past year by -71.11%.
Is HELE a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HELE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 47.1% |
| Analysts Target Price | 28 | 47.1% |
| ValueRay Target Price | 10.5 | -45.1% |
HELE Fundamental Data Overview January 15, 2026
P/S = 0.239
P/B = 0.5084
P/EG = 0.9718
Revenue TTM = 1.80b USD
EBIT TTM = -252.8m USD
EBITDA TTM = -198.9m USD
Long Term Debt = 869.0m USD (from longTermDebt, last quarter)
Short Term Debt = 23.4m USD (from shortTermDebt, last quarter)
Debt = 946.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 919.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.35b USD (430.8m + Debt 946.9m - CCE 29.7m)
Interest Coverage Ratio = -4.30 (Ebit TTM -252.8m / Interest Expense TTM 58.8m)
EV/FCF = 16.70x (Enterprise Value 1.35b / FCF TTM 80.7m)
FCF Yield = 5.99% (FCF TTM 80.7m / Enterprise Value 1.35b)
FCF Margin = 4.48% (FCF TTM 80.7m / Revenue TTM 1.80b)
Net Margin = -43.98% (Net Income TTM -792.5m / Revenue TTM 1.80b)
Gross Margin = 46.72% ((Revenue TTM 1.80b - Cost of Revenue TTM 960.2m) / Revenue TTM)
Gross Margin QoQ = 46.87% (prev 44.16%)
Tobins Q-Ratio = 0.58 (Enterprise Value 1.35b / Total Assets 2.34b)
Interest Expense / Debt = 1.67% (Interest Expense 15.9m / Debt 946.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -199.7m (EBIT -252.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.81 (Total Current Assets 1.00b / Total Current Liabilities 554.1m)
Debt / Equity = 1.11 (Debt 946.9m / totalStockholderEquity, last quarter 852.3m)
Debt / EBITDA = -4.63 (negative EBITDA) (Net Debt 919.7m / EBITDA -198.9m)
Debt / FCF = 11.40 (Net Debt 919.7m / FCF TTM 80.7m)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = -29.83% (Net Income -792.5m / Total Assets 2.34b)
RoE = -67.60% (Net Income TTM -792.5m / Total Stockholder Equity 1.17b)
RoCE = -12.39% (EBIT -252.8m / Capital Employed (Equity 1.17b + L.T.Debt 869.0m))
RoIC = -9.67% (negative operating profit) (NOPAT -199.7m / Invested Capital 2.07b)
WACC = 4.25% (E(430.8m)/V(1.38b) * Re(10.69%) + D(946.9m)/V(1.38b) * Rd(1.67%) * (1-Tc(0.21)))
Discount Rate = 10.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.65%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈97.5m ; Y1≈64.0m ; Y5≈29.2m
Fair Price DCF = 0.47 (EV 930.6m - Net Debt 919.7m = Equity 10.8m / Shares 23.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -57.23 | EPS CAGR: -9.73% | SUE: -0.21 | # QB: 0
Revenue Correlation: -55.03 | Revenue CAGR: -3.32% | SUE: 0.61 | # QB: 0
EPS next Quarter (2026-05-31): EPS=-0.01 | Chg30d=-0.242 | Revisions Net=-2 | Analysts=3
EPS next Year (2027-02-28): EPS=3.38 | Chg30d=-0.823 | Revisions Net=-5 | Growth EPS=-2.6% | Growth Revenue=+0.6%
Additional Sources for HELE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle